ACP Journal Club: Percutaneous closure of the left atrial appendage was noninferior to warfarin in atrial fibrillation.

Authors : Sobieraj-Teague Magdalena M; Eikelboom John J;

Affiliations : McMaster University, Hamilton, Ontario, Canada.

Journal : Ann. Intern. Med.   (2009)

Related Links: Pubmed | Publisher website

New pharmacotherapy for stroke prevention in atrial fibrillation: Update 2010.

Authors : Armaganijan Luciana L; Eikelboom John J; Healey Jeff S JS; Morillo Carlos A CA;

Affiliations : Department of Medicine, Cardiology Division, Arrhythmia Service, McMaster University, HHSC, David Braley CVSRI, Hamilton, Ontario, Canada, L8L 2X2.

Journal : Adv Ther   (2009)

Related Links: Pubmed | Publisher website

Another oral thrombin inhibitor for stroke preventionin atrial fibrillation?

Authors : Eikelboom John W JW; Weitz Jeffrey I JI;

Affiliations : N/A

Journal : Thromb. Haemost.   (2010)

Related Links: Pubmed | Publisher website

Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment.

Authors : Eikelboom John W JW; O'Donnell Martin M; Yusuf Salim S; Diaz Rafael R; Flaker Greg G; Hart Robert R; Hohnloser Stefan S; Joyner Campbell C; Lawrence Jack J; Pais Prem P; Pogue Janice J; Synhorst David D; Connolly Stuart J SJ;

Affiliations : Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada L8L 2X2. eikelbj@mcmaster.ca

Journal : Am. Heart J.   (2010)

Related Links: Pubmed | Publisher website

Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events.

Authors : Hankey Graeme J GJ; Eikelboom John W JW;

Affiliations : Department of Neurology, Royal Perth Hospital, Australia. gjhankey@cyllene.uwa.edu.au

Journal : Lancet Neurol   (2010)

Related Links: Pubmed | Publisher website

Does dabigatran improve stroke-prevention in atrial fibrillation?

Authors : Eikelboom J W JW; Wallentin L L; Yusuf S S; Ezekowitz M D MD; Reilly P A PA; Brueckmann M M; Clemens A A; Connolly S J SJ;

Affiliations : Population Health Research Institute, McMaster University, Hamilton, Canada.

Journal : N/A   (2010)

Related Links: Pubmed | Publisher website

Underuse of evidence-based warfarin dosing methods for atrial fibrillation patients.

Authors : Nieuwlaat Robby R; Barker Lucy L; Kim Yang-Ki YK; Haynes R Brian RB; Eikelboom John W JW; Yusuf Salim S; Connolly Stuart J SJ;

Affiliations : Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada. Robby.Nieuwlaat@phri.ca

Journal : Thromb. Res.   (2010)

Related Links: Pubmed | Publisher website

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

Authors : John W. Eikelboom, MBBS; Lars Wallentin, MD; Stuart J. Connolly, MD; Mike Ezekowitz, MD; Jeff S. Healey, MD; Jonas Oldgren, MD; Sean Yang, BComSc; Marco Alings, MD; Scott Kaatz, DO; Stefan H. Hohnloser, MD; Hans-Christoph Diener, MD; Maria Grazia Franzosi, PhD; Kurt Huber, MD; Paul Reilly, MD; Jeanne Varrone, MD;

Affiliations : Correspondence to John Eikelboom, MBBS, Population Health Research Institute, 237 Barton St E, Hamilton, Ontario, Canada L8L 2X2. E-mail eikelbj@mcmaster.ca

Journal : Circulation   (2011)

Related Links: Pubmed | Publisher website

Apixaban in Patients with Atrial Fibrillation

Authors : Connolly SJ; Eikelboom J; Joyner C; Diener HC; Hart R; Golitsyn S; Flaker G; Avezum A; Hohnloser SH; Diaz R; Talajic M; Zhu J; Pais P; Budaj A; Parkhomenko A; Jansky P; Commerford P; Tan RS; Sim KH; Lewis BS; Van Mieghem W; Lip GY; Kim JH; Lanas-Zanetti F; Gonzalez-Hermosillo A; Dans AL; Munawar M; O'Donnell M; Lawrence J; Lewis G; Afzal R; Yusuf S;

Affiliations : Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada. stuart.connolly@phri.ca

Journal : The New England Journal of medicine   (2011)

Related Links: Pubmed | Publisher website

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

Authors : John W. Eikelboom, MBBS; Lars Wallentin, MD; Stuart J. Connolly, MD; Mike Ezekowitz, MD; Jeff S. Healey, MD; Jonas Oldgren, MD; Sean Yang, BComSc; Marco Alings, MD; Scott Kaatz, DO; Stefan H. Hohnloser, MD; Hans-Christoph Diener, MD; Maria Grazia Franzosi, PhD; Kurt Huber, MD; Paul Reilly, MD; Jeanne Varrone, MD;

Affiliations : Correspondence to John Eikelboom, MBBS, Population Health Research Institute, 237 Barton St E, Hamilton, Ontario, Canada L8L 2X2. E-mail eikelbj@mcmaster.ca

Journal : N/A   (2011)

Related Links: Pubmed | Publisher website

Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: A nested case control analysis of the ACTIVE W study

Authors : Nieuwlaat R; Connolly BJ; Hubers LM; Cuddy SM; Eikelboom JW; Yusuf S;

Affiliations : Corresponding author at: Population Health Research Institute, 237 Barton Street East, L8L 2X2 Hamilton (ON), Canada. Tel.: +1 905 527 4322; fax: +1 905 297 3785. On behalf of the ACTIVE Investigators.

Journal : Thrombosis Research   (2011)

Related Links: Pubmed | Publisher website

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.

Authors : Eikelboom JW; Wallentin L; Connolly SJ; Ezekowitz M; Healey JS; Oldgren J; Yang S; Alings M; Kaatz S; Hohnloser SH; Diener HC; Franzosi MG; Huber K; Reilly P; Varrone J;

Affiliations : Correspondence to John Eikelboom, MBBS, Population Health Research Institute, 237 Barton St E, Hamilton, Ontario, Canada L8L 2X2. E-mail eikelbj@mcmaster.ca

Journal : Circulation   (2011)

Related Links: Pubmed | Publisher website

Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial

Authors : Hohnloser, MD; Jonas Oldgren, MD; Sean Yang, PhD; Lars Wallentin, MD; Michael Ezekowitz, MD; Paul Reilly, MD; John Eikelboom, MD; Martina Brueckmann, MD; Salim Yusuf, MD;

Affiliations : Correspondence to Stefan H. Hohnloser, MD, FACC, FESC, FHRS, Division of Clinical Electrophysiology, J.W. Goethe University Hospital, Theodor-Stern-Kai 7, D 60590 Frankfurt, Germany. E-mail Hohnloser@em.uni-frankfurt.de

Journal : Original Articles   (2012)

Related Links: Pubmed | Publisher website